Focal brachytherapy as definitive treatment for localized prostate cancer: A systematic review and meta-analysis
- 2 March 2024
- journal article
- review article
- Published by Elsevier in Brachytherapy
- Vol. 23 (3) , 309-320
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expectedWorld Journal of Urology, 2023
- Role of MRI for the detection of prostate cancerWorld Journal of Urology, 2021
- PET/MRI in prostate cancer: a systematic review and meta-analysisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- Focal high-dose-rate brachytherapy for localized prostate cancer: toxicity and preliminary biochemical resultsStrahlentherapie und Onkologie, 2020
- MRI targeted single fraction HDR Brachytherapy for localized Prostate Carcinoma: a feasibility study of focal radiation therapy (ProFocAL)European Radiology, 2019
- Long‐term outcomes of partial prostate treatment with magnetic resonance imaging‐guided brachytherapy for patients with favorable‐risk prostate cancerCancer, 2018
- Focal brachytherapy for localized prostate cancer: Urinary toxicity depends on tumor locationBrachytherapy, 2017
- Focal high-dose-rate brachytherapy: A dosimetric comparison of hemigland vs. conventional whole-gland treatmentBrachytherapy, 2013
- Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRIEuropean Radiology, 2009
- Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostateCancer, 2004